ClinicalMetric / Countries / Japan / atherosclerosis
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

atherosclerosis Clinical Trials in Japan

Active clinical trials for atherosclerosis with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan

Active Trials in Japan (2)

NCT05325034
Recruiting

Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

Enrollment
2,000 pts
Country
🇯🇵 Japan
Stephen Nicholls
View Trial →
NCT06694012
Recruiting

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Enrollment
2,000 pts
Country
🇯🇵 Japan
Osaka Metropolitan University
View Trial →

Frequently Asked Questions

How many atherosclerosis clinical trials are active in Japan?
There are currently 2 active clinical trials for atherosclerosis with sites in Japan, of which 2 are actively recruiting patients.
How can I join a atherosclerosis clinical trial in Japan?
To join a atherosclerosis clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are atherosclerosis trials in Japan?
Active atherosclerosis trials in Japan span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global atherosclerosis Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology